OHSU conducts coronavirus vaccine trial

By Celina Tebor (Portland, OR)
Dec. 18, 2020 4:30 p.m. Updated: Dec. 18, 2020 6:33 p.m.

Broadcast: Monday, Dec. 21

An aerial photograph shows the Oregon Health & Science University campus in Southwest Portland, Ore.

Aaron Bieleck / OHSU

Your browser doesn’t support HTML5 audio
THANKS TO OUR SPONSOR:

OHSU has gathered 13,000 volunteers for its Phase 3 AstraZeneca coronavirus vaccine trial two weeks after it was announced. The university is the only Oregon institution participating in the nationwide trial. We speak with Dr. Marcel Curlin, the lead researcher of the study and associate professor of medicine within OHSU’s infectious disease division.

Contact “Think Out Loud®”

If you’d like to comment on any of the topics in this show, or suggest a topic of your own, please get in touch with us on Facebook or Twitter, send an email to thinkoutloud@opb.org, or you can leave a voicemail for us at 503-293-1983. The call-in phone number during the noon hour is 888-665-5865.

THANKS TO OUR SPONSOR:
THANKS TO OUR SPONSOR:
THANKS TO OUR SPONSOR: